10X GENOMICS INC-CLASS A (TXG)

US88025U1097 - Common Stock

27.59  +0.69 (+2.57%)

After market: 27.14 -0.45 (-1.63%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to TXG. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 56.61. This target is 105.18% above the current price.
TXG was analyzed by 20 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TXG.
In the previous month the buy percentage consensus was at a similar level.
TXG was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 27.5930.3060.1856.6173.50 - 9.82% 118.12% 105.18% 166.40%
Up and Down Grades
Date Firm Action Rating
2024-04-18 Deutsche Bank Maintains Buy -> Buy
2024-04-10 Barclays Maintains Overweight -> Overweight
2024-02-16 Stifel Maintains Buy -> Buy
2024-01-25 Barclays Maintains Overweight -> Overweight
2023-12-14 Guggenheim Initiate Buy
2023-12-13 Wolfe Research Initiate Outperform
2023-12-12 B of A Securities Upgrade Underperform -> Neutral
2023-09-29 Barclays Maintains Overweight -> Overweight
2023-09-19 Canaccord Genuity Reiterate Buy -> Buy
2023-08-07 Morgan Stanley Reiterate Overweight -> Overweight
2023-08-04 Barclays Maintains Overweight -> Overweight
2023-08-04 Citigroup Maintains Buy -> Buy
2023-07-13 Goldman Sachs Maintains Sell -> Sell
2023-05-18 Stephens & Co. Reiterate Overweight -> Overweight
2023-05-10 Barclays Initiate Overweight
2023-05-04 TD Cowen Maintains Outperform
2023-05-04 Stephens & Co. Reiterate Overweight
2023-05-04 Stifel Maintains Buy
2023-05-04 Canaccord Genuity Maintains Buy
2023-03-31 Stephens & Co. Initiate Overweight
2023-02-16 Cowen & Co. Maintains Outperform
2023-02-16 Canaccord Genuity Maintains Buy
2023-02-16 Morgan Stanley Maintains Overweight
2023-02-02 UBS Initiate Neutral
2022-12-14 Deutsche Bank Initiate Buy
2022-11-04 Morgan Stanley Maintains Overweight
2022-10-13 Goldman Sachs Maintains Sell
2022-08-18 Goldman Sachs Downgrade Neutral -> Sell
2022-08-10 Morgan Stanley Maintains Overweight
2022-07-15 William Blair Downgrade Outperform -> Market Perform